Shiao Y. Woo, M.D.


M.B., B.S., University of Malaysia, Kuala Lumpur, Malaysia, Faculty of Medicine, 1972
Clinical Internship, Ipoh General Hospital, Ipoh, Malaysia, 6/1972−5/1973
Residency in Internal Medicine, Johor Baru General Hospital, Johor Baru, Malaysia, 6/1973−5/1975
Residency in Pediatrics, Southern General Hospital, Glasgow, Scotland, United Kingdom, 1/1976−5/1976
Residency in Pediatrics, Georgetown University Hospital, Washington, DC, 10/1976−6/1978
Fellowship in Pediatric and Adolescent Oncology-Hematology, Vincent T. Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, 7/1978−6/1980
Residency in Radiation Therapy, Stanford University Medical Center, Stanford, CA, 7/1985−6/1988

Board Certification
M.R.C.P. (U.K.), Specialty Board in Internal Medicine, U.K., 1975
Diploma of Child Health, London, 1976
American Board of Pediatrics, 1980
Subspecialty Board in Pediatric-Hematology-Oncology, 1980
American Board of Radiology-(Radiation Oncology), 1988

Curriculum Vitae

Current Positions:

Professor (Tenured) and Chairman, Department of Radiation Oncology, University of Louisville, School of Medicine
Professor (Tenured), Department of Pediatrics, Kosair Children’s Hospital/Norton Healthcare Chair in Pediatric Oncology, University of Louisville, School of Medicine

Clinical Focus and Research:

Brain and spine tumors, Pediatric cancer, lung cancer

Literature Cited:

  1. Merchant T, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley D, Sexton M, Kellie SJ, Ahern V,  Gajjar A. Multi-Institution prospective trial of reduced- dose craniospinal irradiation (23.4 GY) followed by conformal posterior fossa (36 GY) and primary site irradiation (55.8 GY) and dose-intensive chemotherapy for average-risk medullablastoma. Intl J Rad Oncol Biol Phys 70:782-787, 2008.
  2. Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng &, Taddei PJ, Mirkovic D, Mohan, R, Cox JD, Woo S.  The risk of developing a second cancer after receiving craniospinal proton irradiation.  Phys Med Biol 54(8):2277-91, 2009.
  3. McGovern S, Aldape K, Munsell M, Mahajan A. DeMonte F, Woo SY.  A comparison of WHO grades at recurrents in patients with non-skull base and skull base meningiomas.  J of Neurosurg. 112:925-933, 2010.
  4. Moeller BJ, Chintagumpala M, Philip JJ, Grosshans DR, McAleer MF, Woo SY, Gidley PW, Vats TS, Mahajan A.  Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.  Radiat Oncol, 6:58, June 2, 2011.
  5. Amsbaugh MJ, Grosshans DR, McAleer MF, Zhu R, Wages C, Crawford CN, Palmer M, DeGracia B, Woo S, Mahajan A.  Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes.  Int J Radiat Oncol Biol Phys 83(5):1419-24 August 1, 2012 (Epub January 13, 2012.)

PubMed Information